Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hypertension

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 79 articles:
HTML format
Text format



Single Articles


    December 2019
  1. CRUMP C, Sundquist J, Sundquist K
    Risk of hypertension into adulthood in persons born prematurely: a national cohort study.
    Eur Heart J. 2019 Dec 23. pii: 5686008. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2019
  2. MATHUR P, Kadavath S, Marsh JD, Mehta JL, et al
    Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs.
    Eur Heart J. 2019 Nov 14. pii: 5625542. doi: 10.1093.
    PubMed     Text format    


    October 2019
  3. HERMIDA RC, Crespo JJ, Dominguez-Sardina M, Otero A, et al
    Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
    Eur Heart J. 2019 Oct 22. pii: 5602478. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. MCCORMACK T, Boffa RJ, Jones NR, Carville S, et al
    The 2018 ESC/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ.
    Eur Heart J. 2019 Oct 7. pii: 5583202. doi: 10.1093.
    PubMed     Text format    


  5. SCHIFFRIN EL, Engert JC
    Periodontitis and hypertension: causally linked by immune mechanisms.
    Eur Heart J. 2019 Oct 7. pii: 5582717. doi: 10.1093.
    PubMed     Text format    


  6. KJELDSEN SE, Os I
    Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH.
    Eur Heart J. 2019 Oct 3. pii: 5580654. doi: 10.1093.
    PubMed     Text format    


    September 2019
  7. OBOKATA M, Kane GC, Reddy YNV, Melenovsky V, et al
    The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
    Eur Heart J. 2019 Sep 12. pii: 5568303. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. CZESNIKIEWICZ-GUZIK M, Osmenda G, Siedlinski M, Nosalski R, et al
    Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy.
    Eur Heart J. 2019 Sep 1. pii: 5556904. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2019
  9. HERMIDA RC
    Treatment of sleep-disordered breathing, alone, is insufficient for proper management of sleep-time hypertension.
    Eur Heart J. 2019 Aug 29. pii: 5556424. doi: 10.1093.
    PubMed     Text format    


  10. MEDIANO O, Sanchez-de-la-Torre M, Garcia-Rio F
    The role of sleep disorders breathing treatment as a modifiable condition for cardiovascular risk associated hypertension.
    Eur Heart J. 2019 Aug 29. pii: 5556423. doi: 10.1093.
    PubMed     Text format    


  11. MANIERO C, Gupta AK, Lobo MD
    Impact of the New ACC/AHA and ESC/ESH Hypertension Guidelines in the UK.
    Eur Heart J. 2019;40:2472-2475.
    PubMed     Text format    


    July 2019
  12. TIWANA J, Yang E
    Clinical Implications of the 2017 ACC/AHA Hypertension Guidelines.
    Eur Heart J. 2019;40:2106-2109.
    PubMed     Text format    


    June 2019
  13. KANDZARI DE
    Renal denervation for hypertension: what is needed, and what is next.
    Eur Heart J. 2019 Jun 15. pii: 5519362. doi: 10.1093.
    PubMed     Text format    


  14. EMRICH IE, Bohm M, Mahfoud F
    The 2018 ESC/ESH Guidelines for the management of arterial hypertension: A German point of view.
    Eur Heart J. 2019;40:1830-1831.
    PubMed     Text format    


  15. GENTILLE LORENTE DI
    Coconut atrium: a rare entity to cause pulmonary hypertension.
    Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
    PubMed     Text format    


    May 2019
  16. KJELDSEN SE, Aksnes TA, Mo R, Klemsdal TO, et al
    Impact of the New ACC/AHA and ESC/ESH Hypertension Guidelines for Norway.
    Eur Heart J. 2019;40:1485-1487.
    PubMed     Text format    


  17. BEANEY T, Burrell LM, Castillo RR, Charchar FJ, et al
    May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.
    Eur Heart J. 2019 May 1. pii: 5481538. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2019
  18. HAEUSLER KG, Huttner HB, Kuramatsu JB
    Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension.
    Eur Heart J. 2019 Apr 21. pii: 5475829. doi: 10.1093.
    PubMed     Text format    


  19. COCA PAYERAS A, Williams B, Mancia G
    Response to 'Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension'.
    Eur Heart J. 2019 Apr 21. pii: 5475833. doi: 10.1093.
    PubMed     Text format    


    March 2019
  20. MORALES-SALINAS A, Kones R
    Concerning the degradation of beta-blocker use in the 2018 ESC/ESH hypertension guidelines.
    Eur Heart J. 2019 Mar 14. pii: 5381105. doi: 10.1093.
    PubMed     Text format    


  21. FEITOSA ADM, Mota-Gomes MA, Nadruz W
    How should treated hypertensive patients with systolic blood pressure below 120 mmHg be managed?
    Eur Heart J. 2019 Mar 11. pii: 5374729. doi: 10.1093.
    PubMed     Text format    


  22. HU C
    C-type Hypertension.
    Eur Heart J. 2019;40:715.
    PubMed     Text format    


    February 2019
  23. ESLER M
    Does increased 24-h ambulatory heart rate identify de facto neurogenic hypertension, and facilitate selection of hypertensive patients for renal denervation?
    Eur Heart J. 2019 Feb 7. pii: 5309047. doi: 10.1093.
    PubMed     Text format    


    January 2019
  24. CZOPEK A, Moorhouse R, Guyonnet L, Farrah T, et al
    A novel role for myeloid endothelin-B receptors in hypertension.
    Eur Heart J. 2019 Jan 17. pii: 5289586. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. SCHIFFRIN EL
    New blood pressure cut-offs, prevalence of hypertension and control, and mood disorders: are patients benefitting from lower cut-offs for defining hypertension?
    Eur Heart J. 2019 Jan 8. pii: 5280831. doi: 10.1093.
    PubMed     Text format    


  26. KIM TH, Yang PS, Yu HT, Jang E, et al
    Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population.
    Eur Heart J. 2019 Jan 4. pii: 5273478. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. BOHM M, Mahfoud F, Townsend RR, Kandzari DE, et al
    Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Eur Heart J. 2019 Jan 4. pii: 5273473. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  28. CASELLI S, Serdoz A, Mango F, Lemme E, et al
    High blood pressure response to exercise predicts future development of hypertension in young athletes.
    Eur Heart J. 2018 Dec 22. pii: 5255629. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. LUSCHER TF
    Arterial and pulmonary hypertension: risk assessment and current pharmacological and interventional management.
    Eur Heart J. 2018;39:4127-4131.
    PubMed     Text format    


  30. ESLER M
    Renal nerve ablation for hypertension: Update from an insider.
    Eur Heart J. 2018;39:4054-4055.
    PubMed     Text format    


  31. OZKAN J
    Thomas Luscher on the revival of renal nerve ablation for hypertension.
    Eur Heart J. 2018;39:4053-4054.
    PubMed     Text format    


    November 2018
  32. KLOK FA, Pruefer D, Rolf A, Konstantinides SV, et al
    Magnetic resonance direct thrombus imaging for pre-operative assessment of acute thrombosis in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2018 Nov 27. pii: 5211203. doi: 10.1093.
    PubMed     Text format    


  33. ATASOY S, Johar H, Peters A, Ladwig KH, et al
    Association of hypertension cut-off values with 10-year cardiovascular mortality and clinical consequences: a real-world perspective from the prospective MONICA/KORA study.
    Eur Heart J. 2018 Nov 21. pii: 5195184. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. TSIOUFIS K, Kreutz R
    ESH Annual Meeting 2018: Reinhold Kreutz reports on the 28th European Meeting on Hypertension and Cardiovascular Protection that took place in Barcelona, Spain, 8-11 June.
    Eur Heart J. 2018;39:3836-3839.
    PubMed     Text format    


    September 2018
  35. GIANNONI A, Masi S
    Arterial hypertension and the turbulent ageing of the aortic valve.
    Eur Heart J. 2018 Sep 12. pii: 5094939. doi: 10.1093.
    PubMed     Text format    


  36. RAHIMI K, Mohseni H, Kiran A, Tran J, et al
    Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults.
    Eur Heart J. 2018 Sep 12. pii: 5094940. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. ESHAK N, Abdelnaby M, Shehata H, Ziada K, et al
    A case of fibrosing mediastinitis complicated by pulmonary hypertension and right-sided heart failure.
    Eur Heart J. 2018 Sep 7. pii: 5092489. doi: 10.1093.
    PubMed     Text format    


  38. ZHAO ZG, Xu YN, Chen M, Feng Y, et al
    Isolated intracranial arterial hypertension.
    Eur Heart J. 2018 Sep 5. pii: 5091011. doi: 10.1093.
    PubMed     Text format    


    August 2018
  39. WILLIAMS B, Mancia G, Spiering W, Agabiti Rosei E, et al
    2018 ESC/ESH Guidelines for the management of arterial hypertension.
    Eur Heart J. 2018 Aug 25. pii: 5079119. doi: 10.1093.
    PubMed     Text format    


  40. VIDAL-PETIOT E, Elbez Y, Luscher TF, Fox KM, et al
    The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients.
    Eur Heart J. 2018 Aug 25. pii: 5077828. doi: 10.1093.
    PubMed     Text format    


  41. NIEBAUER J, Borjesson M, Carre F, Caselli S, et al
    Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC).
    Eur Heart J. 2018 Aug 24. pii: 5079290. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. ALI WE, Bakris GL
    Initial single-pill combinations for antihypertensive treatment: greater cardiovascular mortality reduction yet still not used.
    Eur Heart J. 2018 Aug 21. pii: 5077319. doi: 10.1093.
    PubMed     Text format    


    July 2018
  43. REA F, Corrao G, Merlino L, Mancia G, et al
    Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension.
    Eur Heart J. 2018 Jul 27. pii: 5060560. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. PETERS R, Anstey KJ, Booth A, Beckett N, et al
    Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort.
    Eur Heart J. 2018 Jul 24. pii: 5058115. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. DIENER HC
    Preventing dementia beyond treating hypertension.
    Eur Heart J. 2018 Jul 20. pii: 5056853. doi: 10.1093.
    PubMed     Text format    


    June 2018
  46. AUER J, Sharman JE, Weber T
    J-curves in hypertension: what do they tell us about treatment of high blood pressure?
    Eur Heart J. 2018 Jun 13. pii: 5037239. doi: 10.1093.
    PubMed     Text format    


  47. ABELL JG, Kivimaki M, Dugravot A, Tabak AG, et al
    Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension.
    Eur Heart J. 2018 Jun 12. pii: 5032485. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  48. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. BURNIER M
    Hypertension Guidelines.
    Eur Heart J. 2018;39:908-910.
    PubMed     Text format    


  50. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  51. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
    Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. MESSERLI FH, Rimoldi SF, Bangalore S
    Changing definition of hypertension in guidelines: how innocent a number game?
    Eur Heart J. 2018 Jan 9. pii: 4794716. doi: 10.1093.
    PubMed     Text format    


    December 2017
  54. GALIE N, Manes A, Dardi F, Palazzini M, et al
    Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease.
    Eur Heart J. 2017 Dec 27. pii: 4780182. doi: 10.1093.
    PubMed     Text format    


  55. BERMEJO J, Yotti R, Garcia-Orta R, Sanchez-Fernandez PL, et al
    Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
    Eur Heart J. 2017 Dec 21. pii: 4769387. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  56. LUSCHER TF
    From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values.
    Eur Heart J. 2017;38:3258-3271.
    PubMed     Text format    


    October 2017
  57. RUIZ-HURTADO G, Ruilope LM
    Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.
    Eur Heart J. 2017 Oct 20. doi: 10.1093.
    PubMed     Text format    


  58. LUSCHER TF
    Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles.
    Eur Heart J. 2017;38:2857-2859.
    PubMed     Text format    


  59. BANGALORE S, Schwamm L, Smith EE, Hellkamp AS, et al
    Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke.
    Eur Heart J. 2017;38:2827-2835.
    PubMed     Text format     Abstract available


    September 2017
  60. SCHMIEDER RE, Wagner F, Mayr M, Delles C, et al
    The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    Eur Heart J. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. AOKI T, Sugimura K, Tatebe S, Miura M, et al
    Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications.
    Eur Heart J. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available


    August 2017
  63. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  64. WEATHERALD J, Sitbon O, Humbert M
    Validation of a risk assessment instrument for pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


  65. KYLHAMMAR D, Kjellstrom B, Hjalmarsson C, Jansson K, et al
    A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Eur Heart J. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  66. PATEL RS, Masi S, Taddei S
    Understanding the role of genetics in hypertension.
    Eur Heart J. 2017 May 25. doi: 10.1093.
    PubMed     Text format    


  67. MAHFOUD F, Schmieder RE, Azizi M, Pathak A, et al
    Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    PubMed     Text format    


    April 2017
  68. NIIRANEN TJ, McCabe EL, Larson MG, Henglin M, et al
    Risk for hypertension crosses generations in the community: a multi-generational cohort study.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. LUSCHER TF
    From systemic and pulmonary hypertension to heart failure: novel drugs and devices.
    Eur Heart J. 2017;38:1087-1090.
    PubMed     Text format    


  70. FUKS KB, Weinmayr G, Basagana X, Gruzieva O, et al
    Long-term exposure to ambient air pollution and traffic noise and incident hypertension in seven cohorts of the European study of cohorts for air pollution effects (ESCAPE).
    Eur Heart J. 2017;38:983-990.
    PubMed     Text format     Abstract available


    March 2017
  71. VAN EMPEL V, Knackstedt C, van Paassen P, Brunner-La Rocca HP, et al
    Just air good enough in pulmonary hypertension?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format    


  72. ULRICH S, Hasler ED, Saxer S, Furian M, et al
    Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.
    Eur Heart J. 2017 Mar 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  74. GALIE N, Jansa P, Pulido T, Channick RN, et al
    SERAPHIN haemodynamic sub-study: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Eur Heart J. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. VAN DER FEEN DE, Bartelds B, de Boer RA, Berger RM, et al
    Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.
    Eur Heart J. 2017 Feb 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    PubMed     Text format     Abstract available


    January 2017
  77. MAGGIONI AP, Ruschitzka F
    The year in cardiology 2016: heart failure.
    Eur Heart J. 2017 Jan 2. pii: ehw638. doi: 10.1093.
    PubMed     Text format    


    May 2016
  78. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    PubMed     Text format    


    February 2016
  79. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: